DJIA 17,810.06 91.06 0.51%
NASDAQ 4,712.97 11.10 0.24%
S&P 500 2,063.50 10.75 0.52%
market minute promo

Celgene (NASDAQ: CELG)

108.20 0.85 (0.79%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CELG $108.20 0.79%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $108.25
Previous Close $107.35
Daily Range $107.89 - $109.21
52-Week Range $66.85 - $109.25
Market Cap $86.4B
P/E Ratio 56.20
Dividend (Yield) $0.00 (0.0%)
Volume 3,973,022
Average Daily Volume 5,730,437
Current FY EPS $3.26

Sector

Healthcare

Industry

Drugs

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

News & Commentary

This May Be the Fastest Growing Big Biotech Stock Next Year (Hint: It's Not Gilead Sciences)

Analysts expect that Celgene Corporation will deliver greater earnings per share growth than Gilead Sciences in 2015.

Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan

Trade-Ideas: Celgene (CELG) Is Today's Momo Momentum Stock

Celgene Receives Positive CHMP Opinion For OTEZLA, The First Oral PDE4 Inhibitor For The Treatment O

Celgene Receives Positive CHMP Opinion For OTEZLA, The First Oral PDE4 Inhibitor For The Treatment Of Patients With Psoriasis And Psoriatic Arthritis

Agios (AGIO) Shares Up on Positive AG-120 Study Data - Analyst Blog

Celgene Up on Encouraging Long-Term Phase III Otezla Data - Analyst Blog

Jim Cramer Explains Why Investors Win With Agios Pharmaceuticals (AGIO)

Cramer: Agios Pharmaceuticals' Leukemia Drug Pushing Stock 'Much Higher'

Agios Cancer 'Metabolism' Drug Clears Bone Marrow of Leukemic Cells

Gilead's Value Without Its Hep C Franchise

See More CELG News...

CELG's Top Competitors

CELG $108.20 (0.79%)
Current stock: CELG
AMGN $162.81 (0.08%)
Current stock: AMGN
GILD $100.58 (-0.01%)
Current stock: GILD
$0.00 (0.00%)
Current stock: